| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/21/1994 | CA2100830A1 Use of 1,2,5-oxadiazole-2-oxides for the treatment of erectile dysfunctions |
| 01/21/1994 | CA2100707A1 Specific 1,4-dihydropyridine-3,5-dicarboxylic acid ester, process for its preparation and its pharmaceutical use |
| 01/21/1994 | CA2100610A1 Monensin derivatives |
| 01/21/1994 | CA2100034A1 Amidines derived from 3-aminoethyl indoles and process for the preparation thereof |
| 01/20/1994 | WO1994001552A1 Target antigens of transmission blocking antibodies for malaria parsites |
| 01/20/1994 | WO1994001550A1 Self-stabilized oligonucleotides as therapeutic agents |
| 01/20/1994 | WO1994001547A2 A method for generation of antibodies to cell surface molecules |
| 01/20/1994 | WO1994001545A1 Unstabilising viral quasi-species distributions for avoiding resistance phenomena |
| 01/20/1994 | WO1994001443A1 Therapeutic nucleosides |
| 01/20/1994 | WO1994001437A1 Novel 4-(3-benzofuranyl)piperidinyl and 4-(3-benzothienyl)piperidinyl derivatives and pharmaceutical compositions containing them |
| 01/20/1994 | WO1994001436A1 Dioxcyclobutene derivatives as angiotensin ii antagonists |
| 01/20/1994 | WO1994001435A1 New analgesic and nootropic drugs |
| 01/20/1994 | WO1994001432A1 Imidazole derivatives |
| 01/20/1994 | WO1994001430A1 2,5-diaryl tetrahydro-thiophenes, -furans and analogs for the treatment of inflammatory and immune disorders |
| 01/20/1994 | WO1994001429A1 (3r,4r)-δ6-tetrahydrocannabinol-7-oic acids |
| 01/20/1994 | WO1994001422A1 Pharmaceutical compositions having antiaggregant and vasodilating activities |
| 01/20/1994 | WO1994001421A1 Benzothiazepine and benzoxazepine derivatives as cholecystokinin receptor antagonists |
| 01/20/1994 | WO1994001420A1 Heterocyclic compounds as pharmaceutical |
| 01/20/1994 | WO1994001414A1 Uracil derivatives as enzyme inhibitors |
| 01/20/1994 | WO1994001413A1 Boronated compounds |
| 01/20/1994 | WO1994001412A1 1-arylsulphonyl, arylcarbonyl and 1-arylphosphonyl-3-phenyl-1,4,5,6-tetrahydropyridazines |
| 01/20/1994 | WO1994001408A1 Anilide derivatives |
| 01/20/1994 | WO1994001406A1 Contrast agents for mr diagnosis |
| 01/20/1994 | WO1994001404A1 Novel piperidyl amides, sulfonamides and sulfoxamides as inhibitors of cholesterol biosynthesis |
| 01/20/1994 | WO1994001398A1 Vitamin d analogues |
| 01/20/1994 | WO1994001392A1 (-)-ritodrine |
| 01/20/1994 | WO1994001166A1 Implanting devices for release of neuroinhibitory compounds |
| 01/20/1994 | WO1994001142A1 Therapeutic compositions and methods using pqq |
| 01/20/1994 | WO1994001139A1 Targeting somatic gene therapy to joints |
| 01/20/1994 | WO1994001129A1 Use of myoblasts for sustained delivery of gene products |
| 01/20/1994 | WO1994001127A1 Lysozyme dimer and compositions containing the same |
| 01/20/1994 | WO1994001121A1 Biocidal composition containing mustard seed plant extract |
| 01/20/1994 | WO1994001118A1 Methods for enhancing drug delivery with modified saponins |
| 01/20/1994 | WO1994001117A1 Therapeutic nucleosides |
| 01/20/1994 | WO1994001116A1 Treatment of diseases associated with amyloid formation by using congo red |
| 01/20/1994 | WO1994001115A1 Ophthalmic topical composition containing (s)-timolol hemihydrate |
| 01/20/1994 | WO1994001114A1 Antidepressant |
| 01/20/1994 | WO1994001113A1 Oxytocin antagonist |
| 01/20/1994 | WO1994001112A1 Methods of using (-) cisapride for the treatment of gastro-esophageal reflux disease and other disorders |
| 01/20/1994 | WO1994001111A1 Methods of using (+) cisapride for the treatment of gastro-esophageal reflux disease and other disorders |
| 01/20/1994 | WO1994001110A1 5'-INDOLINYL OXAZOLIDINONES USEFUL AGAINST $i(MYCOBACTERIUM TUBERCULOSIS) |
| 01/20/1994 | WO1994001109A1 4-oxa-1-azabicyclo [3,2,0] heptan-7-one derivatives as antitumor agents |
| 01/20/1994 | WO1994001108A1 Controlled release pilocarpine delivery system |
| 01/20/1994 | WO1994001107A1 Benzimidazoles for alleviating stomach ulcers in swine |
| 01/20/1994 | WO1994001106A1 Use of byakangelicin and its derivative, composition comprising same and method for treating cataract |
| 01/20/1994 | WO1994001105A1 Method of treating hyperproliferative vascular disease |
| 01/20/1994 | WO1994001103A1 Sustained release organic nitrite therapy |
| 01/20/1994 | WO1994001102A1 Aminimide-containing molecules and materials as molecular recognition agents |
| 01/20/1994 | WO1994001101A1 A method of treating reduced insulin-like growth factor and bone loss associated with aging |
| 01/20/1994 | WO1994001100A1 METHODS AND COMPOSITIONS FOR INHIBITING 5α-REDUCTASE ACTIVITY |
| 01/20/1994 | WO1994001099A1 Pharmaceutical composition having anti-alcohol, radioprotecting and anti-choleraic activity and stimulating energy metabolism, stomach mucous membrane acid-generation and secretion functions |
| 01/20/1994 | WO1994001098A1 Fungicide |
| 01/20/1994 | WO1994001097A1 Composition for buccal application containing polyprenyl derivative as active ingredient |
| 01/20/1994 | WO1994001096A1 Methods and products for treating presbyopia |
| 01/20/1994 | WO1994001095A2 Medicaments for the treatment of visceral pain and migraine |
| 01/20/1994 | WO1994001094A1 Drugs for preventing the development of tolerance during treatment with benzodiazepine-receptor-binding substances |
| 01/20/1994 | WO1994001087A1 Precipitation of one or more active compounds in situ |
| 01/20/1994 | WO1994001086A1 Tissue irrigating solutions |
| 01/20/1994 | WO1994001083A1 Composition for dermatologic preparation |
| 01/20/1994 | WO1994001075A1 Composition for dermatologic preparation |
| 01/20/1994 | WO1994001074A1 Composition for dermatologic preparation |
| 01/20/1994 | WO1993021894A3 Treatment of macular degeneration |
| 01/20/1994 | DE4323567A1 Hepatitis B viral infection treatment compsn. - contg. iridoid glycoside or aglycone, e.g. aucubin as low toxicity viral DNA replication inhibitor |
| 01/20/1994 | CA2140140A1 Lysozyme dimer and compositions containing the same |
| 01/20/1994 | CA2140034A1 2,5-diaryl tetrahydro-thiophenes, -furans and analogs for the treatment of inflammatory and immune disorders |
| 01/20/1994 | CA2139930A1 Dioxycyclobutene derivatives as angiotensin ii antagonists |
| 01/20/1994 | CA2139851A1 Method of treating hyperproliferative vascular disease |
| 01/20/1994 | CA2139836A1 Iracil derivatives as enzyme inhibitors |
| 01/20/1994 | CA2139739A1 New analgesic and nootropic drugs |
| 01/20/1994 | CA2139638A1 Methods of using (-) cisapride for the treatment of gastro-esophageal reflux disease and other disorders |
| 01/20/1994 | CA2139636A1 Methods of using (+) cisapride for the treatment of gastro-esophageal reflux disease and other disorders |
| 01/20/1994 | CA2139633A1 4-oxa-1-azabicyclo [3,2,0] heptan-7-one derivatives as antitumor agents |
| 01/20/1994 | CA2139488A1 Drugs for preventing the development of tolerance during treatment with benzodiazepine-receptor-binding substances |
| 01/20/1994 | CA2139442A1 Heterocyclic compounds as pharmaceutical |
| 01/20/1994 | CA2139440A1 Medicaments for the treatment of visceral pain and migraine |
| 01/20/1994 | CA2139437A1 Methods for enhancing drug delivery with modified saponins |
| 01/20/1994 | CA2139417A1 Benzothiazepine and benzoxazepine derivatives |
| 01/20/1994 | CA2139349A1 Aminimide-containing molecules and materials as molecular recognition agents |
| 01/20/1994 | CA2139319A1 Self-stabilized oligonucleotides as therapeutic agents |
| 01/20/1994 | CA2139307A1 1-arylsulphonyl, arylcarbonyl and 1-arylphosphonyl-3-phenyl-1,4,5,6-tetrahydropyridazines |
| 01/20/1994 | CA2139132A1 Therapeutic nucleosides |
| 01/20/1994 | CA2138787A1 Alleviating stomach ulcers in swine |
| 01/20/1994 | CA2138646A1 Target antigens of transmission blocking antibodies for malaria parasites |
| 01/20/1994 | CA2137456A1 Use of myoblasts for sustained delivery of gene products |
| 01/20/1994 | CA2136324A1 5'-indolinyl oxazolidinones useful against mycobacterium tuberculosis |
| 01/20/1994 | CA2131631A1 Vitamin d analogues |
| 01/20/1994 | CA2116455A1 Imidazole derivatives |
| 01/20/1994 | CA2116334A1 Oxytocin antagonist |
| 01/19/1994 | EP0579507A1 Isoxazole derivatives for the treatment of irritable bowel syndrome |
| 01/19/1994 | EP0579496A1 4-Aminoquinazoline derivatives, and their use as medicine |
| 01/19/1994 | EP0579488A1 Composition for treating mastitis and metritis |
| 01/19/1994 | EP0579435A1 Cyclodextrin complexation |
| 01/19/1994 | EP0579421A2 Process for preparing guanine-containing antiviral agents and purinyl salts useful in such process |
| 01/19/1994 | EP0579412A1 1,2,4-trioxygenated benzene derivatives useful as a leukotriene antagonists |
| 01/19/1994 | EP0579333A2 Antibacterial antiplaque oral composition |
| 01/19/1994 | EP0579304A1 Heteroarylnaphthalenes as inhibitors of leukotriene biosynthesis |
| 01/19/1994 | EP0579280A1 Pesticidal method using N-phenylpyrazoles |
| 01/19/1994 | EP0579277A1 Imidazole derivatives, their preparation and their use as synthetic intermediates |
| 01/19/1994 | EP0579263A1 1,4-Substituted piperidines as acetylchozinesterase inhibitors and their use for the treatment of Alzheimer's disease |
| 01/19/1994 | EP0579260A1 Use of a vasodilator for the treatment of pulmonary hypertension and/or right heart failure-related conditions |